CYP2D6

CYP2D6 Gene Overview

What it Does:
The CYP2D6 gene encodes an enzyme that plays a key role in phase I detoxification, responsible for metabolizing and eliminating approximately 25% of commonly used medications. CYP2D6 is also active in the central nervous system, where it:

• Converts tyramine to dopamine (important for brain health).
• Regenerates serotonin and inactivates neurotoxins.

Why This Matters to You:
Variants in the CYP2D6 gene determine your metabolizer status, which affects how efficiently you process medications, detoxify harmful substances, and regulate brain health.

Understanding the CYP2D6 Variants

Key Genotypes & Metabolizer Groups:

1. Normal Metabolizer (*1/*1): No impact on detoxification.
2. Intermediate Metabolizer (*1/*10 or *10/*10): Reduced enzyme activity.
3. Poor Metabolizer (*10/*3, *1/*3, or *3/*3): Significant loss of enzyme function.

1. Intermediate Metabolizer (*1/*10 or *10/*10)

What It Means for You:
Carrying the *10 allele results in decreased CYP2D6 activity, which leads to:

• Detoxification:
• Reduced capacity to metabolize medications and other external toxins.
• Slower clearance of substances may increase the risk of side effects from certain drugs.
• Autoimmune Disease Risk:
• Associated with an increased likelihood of developing systemic lupus erythematosus (SLE), an autoimmune condition characterized by chronic inflammation.

2. Poor Metabolizer (*10/*3, *1/*3, or *3/*3)

What It Means for You:
Carrying the *3 allele results in a complete loss of enzyme function, leading to:

• Detoxification:
• Severe impairment of the body’s ability to metabolize medications and toxins.
• Brain Health & Parkinson’s Disease Risk:
• Reduced production of dopamine from tyramine and decreased ability to inactivate Parkinson’s-causing neurotoxins.
• Associated with an increased risk of Parkinson’s disease (PD).
• Autoimmune Disease Risk:
• Similar to intermediate metabolizers, poor metabolizers are also linked to a higher risk of systemic lupus erythematosus (SLE).

What This Means for You

• If you carry the *1/*10 or *10/*10 genotype (Intermediate Metabolizer):
• Work with your doctor to adjust medication dosages based on your reduced ability to metabolize certain drugs.
• Support your body’s detoxification pathways with a nutrient-dense diet rich in antioxidants (e.g., berries, leafy greens) to counteract oxidative stress.
• Monitor for symptoms of autoimmune conditions and discuss prevention strategies with a healthcare provider.
• If you carry the *10/*3, *1/*3, or *3/*3 genotype (Poor Metabolizer):
• Avoid medications metabolized by CYP2D6 unless specifically recommended by your doctor, as poor metabolizers are at increased risk of side effects.
• Consider brain-healthy lifestyle changes, including regular exercise and a diet high in omega-3 fatty acids (e.g., fish, flaxseeds), to support dopamine production and reduce Parkinson’s risk.
• Discuss routine monitoring for early signs of Parkinson’s disease or other neurodegenerative conditions.

Next Step:
Speak with a genomics specialist or doctor to learn how your CYP2D6 gene impacts your detoxification pathways, medication metabolism, and risk for neurodegenerative or autoimmune conditions. Develop a personalized plan to optimize your health and medication use.